Smartleaf Asset Management
MYGN icon

Smartleaf Asset Management’s Myriad Genetics MYGN Stock Holding History

Smartleaf Asset Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$42 Buy
+10
New +$42 ﹤0.01% 3574
2025
Q3 		– Sell
-384
Closed -$2.02K – 3048
2025
Q2 		$2.02K Sell
384
-38
-9% -$224 ﹤0.01% 2334
2025
Q1 		$3.75K Sell
422
-682
-62% -$8.19K ﹤0.01% 2282
2024
Q4 		$15K Buy
1,104
+721
+188% +$13.3K ﹤0.01% 1805
2024
Q3 		$10.1K Buy
383
+197
+106% +$5.33K ﹤0.01% 1752
2024
Q2 		$4.52K Buy
186
+12
+7% +$263 ﹤0.01% 1852
2024
Q1 		$3.72K Buy
+174
New +$3.74K ﹤0.01% 1314

Other funds holding MYGN

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
OP Asset Management
OP Asset Management Helsinki $11.8B AUM 34.59% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Smartleaf Asset Management's MYGN Position: Q3 2026 in Review

Smartleaf Asset Management opened a new position in Myriad Genetics (MYGN) in Q3 2026: 10 shares worth $42. The stake represents ﹤0.01% of the portfolio and ranks #3574 among its holdings. This is a return to the name: Smartleaf Asset Management previously reported a position in MYGN as recently as Q2 2025.

Smartleaf Asset Management first reported a position in MYGN in Q1 2024 and has held it in 7 quarters since. The position peaked at $15K in Q4 2024. 79 funds tracked by Wall St. Rank hold MYGN as of Q3 2026.

  • Smartleaf Asset Management held 10 shares of Myriad Genetics worth $42 as of Q3 2026.
  • Myriad Genetics was a new Smartleaf Asset Management position in Q3 2026.
  • Myriad Genetics made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #3574 holding.
  • Smartleaf Asset Management first reported a position in Myriad Genetics in Q1 2024 and has held it in 7 quarters since.
  • Smartleaf Asset Management's Myriad Genetics position peaked at $15K in Q4 2024.
  • 79 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.